Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study | Zendy

Kyle P. Murray | Zendy; Jing Zhao | Zendy; Susan L. Davis | Zendy; Ravina Kullar | Zendy; Keith S. Kaye | Zendy; Paul Lephart | Zendy; Michael J. Rybak | Zendy

Open Access

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study

Author(s) -

Kyle P. Murray,

Jing Zhao,

Susan L. Davis,

Ravina Kullar,

Keith S. Kaye,

Paul Lephart,

Michael J. Rybak

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit112

Subject(s) - daptomycin , bacteremia , vancomycin , medicine , minimum inhibitory concentration , staphylococcus aureus , microbiology and biotechnology , staphylococcal infections , methicillin resistant staphylococcus aureus , micrococcaceae , antibacterial agent , antibiotics , bacteria , biology , genetics

Recent reports have described decreased effectiveness with vancomycin treatment for methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) when the vancomycin minimum inhibitory concentration (MIC) is >1 µg/mL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research